[PERSON]
Josh D. Woolley
Featured in 1 tracked story · first seen
Situations
US psychedelic therapy regulatory and research developments
2 clusters · 6 sources · last updated
Latest: Researchers propose new masking framework for psychedelic clinical trials
The U.S. Food and Drug Administration (FDA) is working to develop a new framework to accelerate patient access to psychedelic medicines, such as psilocybin and DMT, to address the national mental health crisis. During a